The hAPP-YAC transgenic model has elevated UPS activity in the frontal cortex similar to Alzheimer's disease and Down's syndrome
DC Field | Value | Language |
---|---|---|
dc.contributor.author | SEO, HYE MYUNG | - |
dc.contributor.author | Isacson, Ole | - |
dc.date.accessioned | 2021-06-23T14:05:58Z | - |
dc.date.available | 2021-06-23T14:05:58Z | - |
dc.date.issued | 2010-09 | - |
dc.identifier.issn | 0022-3042 | - |
dc.identifier.issn | 1471-4159 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/erica/handle/2021.sw.erica/40413 | - |
dc.description.abstract | The ubiquitin-proteasome system (UPS) is critical for handling the intra-cellular load of abnormal and misfolded proteins in several neurodegenerative diseases. First, to determine the effects of the over-expression of human amyloid precursor protein (hAPP) on UPS, we measured proteasome activities using fluorescent substrates in the frontal cortex of hAPP-yeast artificial chromosome (YAC) transgenic (tg) mice (R1.40, hemizygous; Lamb, Nat Genet, 9, 4; 1995). Chymotrypsin and PGPH-like activities of proteasome were increased in frontal cortex of hAPP-YAC tg mice. These proteasome activities (both chymotrypsin and PGPH-like) were further increased by cholinergic stimulation in littermate control mice, but not in hAPP-YAC tg mice. Nerve growth factor (NGF) levels were decreased by hAPP over-expression in the frontal cortex and hippocampus of hAPP-YAC tg mice, and further decreased by M1 agonist treatment in the hippocampus of littermate control and hAPP-YAC tg mice. Interestingly, the frontal cortex (BA9 area) of Alzheimer's disease (AD) patients (Stage 3, n = 11) and Down's syndrome (DS) patients (n = 9) showed similar up-regulation of the UPS activities to those seen in hAPP-YAC tg mice. M1 agonist stimulation increased the activities of α-secretase, which were down-regulated by hAPP over-expression in the frontal cortex of hAPP-YAC tg mice. These results demonstrate that (i) hAPP-YAC tg mice have an up-regulation in the frontal cortex of the UPS similar to AD and DS patients; (ii) muscarinic stimulation increase UPS activities, increase secreted APP (APPs) levels, and decrease amyloid beta 42/40 ratio only in littermate controls, but not in hAPP-YAC tg mice. Taken together, these results suggest that both the adaptive reactions in the proteostatic network and pathological changes in AD and DS need to be considered in the future potential therapeutics. © 2010 International Society for Neurochemistry. | - |
dc.format.extent | 8 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | Blackwell Publishing Inc. | - |
dc.title | The hAPP-YAC transgenic model has elevated UPS activity in the frontal cortex similar to Alzheimer's disease and Down's syndrome | - |
dc.type | Article | - |
dc.publisher.location | 미국 | - |
dc.identifier.doi | 10.1111/j.1471-4159.2010.06902.x | - |
dc.identifier.scopusid | 2-s2.0-77956329435 | - |
dc.identifier.wosid | 000281549600026 | - |
dc.identifier.bibliographicCitation | Journal of Neurochemistry, v.114, no.6, pp 1819 - 1826 | - |
dc.citation.title | Journal of Neurochemistry | - |
dc.citation.volume | 114 | - |
dc.citation.number | 6 | - |
dc.citation.startPage | 1819 | - |
dc.citation.endPage | 1826 | - |
dc.type.docType | Article | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | sci | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Biochemistry & Molecular Biology | - |
dc.relation.journalResearchArea | Neurosciences & Neurology | - |
dc.relation.journalWebOfScienceCategory | Biochemistry & Molecular Biology | - |
dc.relation.journalWebOfScienceCategory | Neurosciences | - |
dc.subject.keywordPlus | 2 ethyl 8 methyl 2,8 diazaspiro[4.5]decane 1,3 dione | - |
dc.subject.keywordPlus | alpha secretase | - |
dc.subject.keywordPlus | amyloid beta protein[1-40] | - |
dc.subject.keywordPlus | amyloid beta protein[1-42] | - |
dc.subject.keywordPlus | amyloid precursor protein | - |
dc.subject.keywordPlus | chymotrypsin | - |
dc.subject.keywordPlus | nerve growth factor | - |
dc.subject.keywordPlus | proteasome | - |
dc.subject.keywordPlus | ubiquitin | - |
dc.subject.keywordPlus | amyloid precursor protein | - |
dc.subject.keywordPlus | muscarinic M1 receptor | - |
dc.subject.keywordPlus | nerve growth factor | - |
dc.subject.keywordPlus | proteasome | - |
dc.subject.keywordPlus | secretase | - |
dc.subject.keywordPlus | ubiquitin | - |
dc.subject.keywordPlus | Alzheimer disease | - |
dc.subject.keywordPlus | animal experiment | - |
dc.subject.keywordPlus | animal model | - |
dc.subject.keywordPlus | animal tissue | - |
dc.subject.keywordPlus | article | - |
dc.subject.keywordPlus | cholinergic stimulation | - |
dc.subject.keywordPlus | controlled study | - |
dc.subject.keywordPlus | down regulation | - |
dc.subject.keywordPlus | Down syndrome | - |
dc.subject.keywordPlus | frontal cortex | - |
dc.subject.keywordPlus | gene overexpression | - |
dc.subject.keywordPlus | hippocampus | - |
dc.subject.keywordPlus | human | - |
dc.subject.keywordPlus | mouse | - |
dc.subject.keywordPlus | nonhuman | - |
dc.subject.keywordPlus | priority journal | - |
dc.subject.keywordPlus | protein secretion | - |
dc.subject.keywordPlus | transgenic mouse | - |
dc.subject.keywordPlus | upregulation | - |
dc.subject.keywordPlus | yeast artificial chromosome | - |
dc.subject.keywordPlus | agonists | - |
dc.subject.keywordPlus | Alzheimer disease | - |
dc.subject.keywordPlus | animal | - |
dc.subject.keywordPlus | biosynthesis | - |
dc.subject.keywordPlus | Down syndrome | - |
dc.subject.keywordPlus | frontal lobe | - |
dc.subject.keywordPlus | genetics | - |
dc.subject.keywordPlus | metabolism | - |
dc.subject.keywordPlus | Mus | - |
dc.subject.keywordPlus | Mus musculus | - |
dc.subject.keywordPlus | Alzheimer Disease | - |
dc.subject.keywordPlus | Amyloid beta-Protein Precursor | - |
dc.subject.keywordPlus | Amyloid Precursor Protein Secretases | - |
dc.subject.keywordPlus | Animals | - |
dc.subject.keywordPlus | Chromosomes, Artificial, Yeast | - |
dc.subject.keywordPlus | Down Syndrome | - |
dc.subject.keywordPlus | Frontal Lobe | - |
dc.subject.keywordPlus | Humans | - |
dc.subject.keywordPlus | Mice | - |
dc.subject.keywordPlus | Mice, Transgenic | - |
dc.subject.keywordPlus | Nerve Growth Factor | - |
dc.subject.keywordPlus | Proteasome Endopeptidase Complex | - |
dc.subject.keywordPlus | Receptor, Muscarinic M1 | - |
dc.subject.keywordPlus | Ubiquitin | - |
dc.subject.keywordPlus | Up-Regulation | - |
dc.subject.keywordAuthor | amyloid precursor protein | - |
dc.subject.keywordAuthor | cortex | - |
dc.subject.keywordAuthor | patient | - |
dc.subject.keywordAuthor | proteasome | - |
dc.subject.keywordAuthor | transgenic mice | - |
dc.subject.keywordAuthor | ubiquitin | - |
dc.identifier.url | https://onlinelibrary.wiley.com/doi/10.1111/j.1471-4159.2010.06902.x | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
55 Hanyangdeahak-ro, Sangnok-gu, Ansan, Gyeonggi-do, 15588, Korea+82-31-400-4269 sweetbrain@hanyang.ac.kr
COPYRIGHT © 2021 HANYANG UNIVERSITY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.